EpiSign Complete – Methylation analysis

Test code: AUA00001
To add a test to your selection, Choose ONE clinical indication. Additional information must be specified when Order test
Clear

Epigenetic test: EpiSign Complete.Check the disclaimer, the latest syndromes and corresponding genes included in this panel. Specify suspicion of one of the syndromes when ordering the test.

Indications

Suitable for patients with developmental delay, or with one or more overlapping features suggestive of one of the represented epigenetic signature conditions or imprinting disorders.

Detection

Methylation abnormalities detected using this test may require additional targeted genetic testing. This test will not detect females with Fragile X (FMR1) expansions.

Lab method

EpiSign, Methylation Analysis

Turnaround time

4 months

Location

Location AMC

Price  1.050,00

Category:

  • a syndrome for Mental Retardation
  • ADNP related syndrome
  • Alpha-thalassemia mental retardation (ATRX) syndrome (OMIM: 301040)
  • Angelman syndrome - AS (OMIM: 105830)
  • Autism, susceptibility to, 18 (OMIM: 615032)
  • BAFopathies
  • Blepharophimosis SMARCA2 Synd
  • Cerebellar ataxia, deafness and narcolepsy a.d. ADCADN syndrome - DNMT1 (OMIM: 604121)
  • CHARGE syndrome (OMIM: 214800)
  • Claes-Jensen syndrome
  • Cornelia de Lange syndrome
  • Down syndrome (OMIM: 602523)
  • Floating Harbor syndrome
  • Fragile X syndrome (Affected males only) (OMIM: 300624)
  • Genitopatellar syndrome
  • Kabuki syndrome
  • Kagami–Ogata syndrome UPD14 (OMIM: 608149)
  • Mental retardation, FRA12A type (OMIM: 136630)
  • Prader Willi syndrome - PWS (OMIM: 176270)
  • Silver-Russell syndrome - SRS (OMIM: 180860)
  • Sotos syndrome
  • Temple syndrome (OMIM: 616222)
  • Methylation disorders
  • Beckwith Wiedemann syndrome - BWS (OMIM: 130650)

Other tests: